Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02391584 · ClinicalTrials.gov registry record · NA

XprESS Eustachian Tube Dilation Study

A NA study, sponsored by Entellus Medical.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02391584 is a NA study that has completed, run by Entellus Medical. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02391584, a NA study, has completed, sponsored by Entellus Medical.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.

Interventions

  • OTHER Control
  • DEVICE XprESS

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-02
Est. Completion 2017-10
Phase NA

Sponsor

Entellus Medical

11 total trials

What the Registry Record Tells You About NCT02391584

The ClinicalTrials.gov registry entry for NCT02391584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Entellus Medical, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT02391584 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02391584 about?

NCT02391584 is a clinical study titled "XprESS Eustachian Tube Dilation Study". Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.

What is the current status of trial NCT02391584?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-02. Estimated completion is 2017-10.

What interventions are being tested in trial NCT02391584?

The interventions under investigation include: Control (OTHER), XprESS (DEVICE).

Who is sponsoring clinical trial NCT02391584?

This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.